TAM
VYGR icon

Tocqueville Asset Management’s Voyager Therapeutics VYGR Stock Holding History

Tocqueville Asset Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-28,655
Closed -$493K – 773
2019
Q3 		$493K Buy
28,655
+5,830
+26% +$122K 0.01% 565
2019
Q2 		$621K Sell
22,825
-7,600
-25% -$174K 0.01% 554
2019
Q1 		$582K Buy
30,425
+2,425
+9% +$31.6K 0.01% 561
2018
Q4 		$263K Sell
28,000
-19,575
-41% -$251K ﹤0.01% 650
2018
Q3 		$900K Buy
47,575
+10,500
+28% +$201K 0.01% 519
2018
Q2 		$724K Buy
37,075
+7,350
+25% +$145K 0.01% 556
2018
Q1 		$559K Hold
29,725
– – 0.01% 592
2017
Q4 		$493K Buy
+29,725
New +$510K 0.01% 615

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Tocqueville Asset Management's VYGR Position: Q4 2019 in Review

Tocqueville Asset Management sold out of Voyager Therapeutics (VYGR) in Q4 2019, closing a stake of 28,655 shares — an estimated $493K sold.

Tocqueville Asset Management first reported a position in VYGR in Q4 2017 and held it in 8 quarters. The position peaked at $900K in Q3 2018. 138 funds tracked by Wall St. Rank hold VYGR as of Q4 2019.

  • Tocqueville Asset Management reported no remaining Voyager Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Tocqueville Asset Management sold 28,655 Voyager Therapeutics shares in Q4 2019, an estimated $493K.
  • Tocqueville Asset Management first reported a position in Voyager Therapeutics in Q4 2017 and held it in 8 quarters.
  • Tocqueville Asset Management's Voyager Therapeutics position peaked at $900K in Q3 2018.
  • 138 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2019.

Based on Tocqueville Asset Management's 13F filing for Q4 2019, filed 14 Jan 2020.